Cargando…
Circumvention of 5‐Fluorouracil Resistance in Human Stomach Cancer Cells by Uracil Phosphoribosyltransferase Gene Transduction
A human stomach cancer cell line with acquired resistance to 5‐fluorouracil (5‐FU), NUGC‐3/5FU/L, has been found to possess reduced ability to convert 5‐FU into active metabolites. We attempted in vitro gene therapy for this 5‐FU‐resistant cell line. NUGC‐3 and NUGC‐3/5FU/L cells were infected with...
Autores principales: | Inaba, Makoto, Sawada, Hiroko, Sadata, Akiko, Hamada, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926061/ https://www.ncbi.nlm.nih.gov/pubmed/10359051 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00754.x |
Ejemplares similares
-
Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells
por: Inaba, Makoto, et al.
Publicado: (1996) -
Biochemical Characterization of Uracil Phosphoribosyltransferase from Mycobacterium tuberculosis
por: Villela, Anne Drumond, et al.
Publicado: (2013) -
Increased Sensitivity to Long‐term 5‐Fluorouracil Exposure of Human Colon Cancer HT‐29 Cells Resistant to Short‐term Exposure
por: Inaba, Makoto, et al.
Publicado: (1998) -
Linking uracil base excision repair and 5-fluorouracil toxicity in yeast
por: Seiple, Lauren, et al.
Publicado: (2006) -
Circumvention of Atypical Multidrug Resistance with Tumor Necrosis Factor
por: Cimoli, Guido, et al.
Publicado: (1994)